Simulations Plus

Update in progress

SLP (NasdaqGS)

Simulations Plus, Inc. develops AI- and ML-based software for drug discovery and development, with Software and Services offerings globally. It provides GastroPlus for human and animal absorption, biopharmaceutics, PK/PD; DDDPlus and MembranePlus; mechanistic models such as DILIsym, NAFLDsym, ILDsym, IPFsym, RENAsym, MITOsym, OBESITYsym, and Thales; ADMET predictor; MedChem Designer; and MonolixSuite for population analyses and regulatory submissions. It also offers pharmacology consulting and early discovery services. Based in RTP, NC.